Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

Liarozole

SKU: orb1219076

Description

Liarozole is a cytochrome P450 (CYP450) dependent inhibitor, orally active, it also a potent inhibitor of estrogen (via inhibition of aromatase) and testicular androgen synthesis (inhibition of 17 ,20-lyase).Liarozole dihydrochloride is an imidazole derivative; it is being investigated as a non-hormonal agent in prostate cancer and in the treatment of various other cancers and skin disorders. (In Vitro):Liarozole (0.01~10 μM; 9 days; MCF-7 cells) inhibits cells proliferation.Liarozole (1 μM; 4 days; mesenchymal cells) completely inhibits chondrogenesis.(In Vivo):Liarozole (5-20 mg/kg; p.o.; 3 days) reverses the vaginal keratosis caused by estrogen stimulation.Liarozole (40 mg/kg; p.o.; 21 days) reduces tumor burden substantially.

Images & Validation

Key Properties

CAS Number115575-11-6
MW308.76
Purity>98% (HPLC)
FormulaC17H13ClN4
SMILESClC1=CC(C(C2=CC=C3NC=NC3=C2)N4C=CN=C4)=CC=C1
TargetP450
SolubilityDMSO:10 mM

Bioactivity

In Vivo
Liarozole (5-20 mg/kg; p.o. ; 3 days) reverses the vaginal keratosis caused by estrogen stimulation. Liarozole (40 mg/kg; p.o. ; 21 days) reduces tumor burden substantially. Animal model: Ovariectomized rats. Dosage: 5~20 mg/kg. Administration: p.o. ; 3 days. Result: Reversed the vaginal keratosis caused by estrogen stimulation. Animal model: SCID mice. Dosage: 40 mg/kg. Administration: p.o. ; 21 days. Result: Inhibited tumor growth and survival.
In Vitro
Liarozole (0.01~10 μM; 9 days; MCF-7 cells) inhibits cells proliferation. Liarozole (1 μM; 4 days; mesenchymal cells) completely inhibits chondrogenesis. Cell Proliferation Assay Cell line: MCF-7 cells. Concentration: 0.01~10 μM Incubation time: 9 days. Result: Had an effect of 35% inhibition at 10 μM on cell proliferation. Cell Differentiation Assay Cell line: Mesenchymal cells. Concentration: 1 μM. Incubation time: 4 days. Result: Completely inhibited chondrogenesis.

Storage & Handling

StorageStorage temperature: -20°C. Stability: ≥ 2 years
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

R75251 dihydrochloride

Similar Products

  • Liarozole HCl [orb1702016]

    145858-50-0

    345.23

    C17H14Cl2N4

    50 mg, 100 mg, 25 mg
  • Liarozole fumarate [orb1702017]

    145858-52-2

    482.88

    C17H13ClN4·3/2C4H4O4

    25 mg, 50 mg, 100 mg
  • Liarozole dihydrochloride [orb1709261]

    1883548-96-6

    381.69

    C17H15Cl3N4

    10 mg
  • Liarozole [orb1309484]

    99.38% (May vary between batches)

    115575-11-6

    308.76

    C17H13ClN4

    1 mg, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg, 1 ml x 10 mM (in DMSO)
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Protocol Information

Available Sizes

Select a size below

500 mg
200 mg
5 mg
$ 320.00
10 mg
$ 520.00
25 mg
$ 870.00
50 mg
$ 1,220.00
100 mg
$ 1,730.00